A computational model for telomere-dependent cell-replicative aging

BioSystems

Volumn 91, Issue 1, 2008, Pages 262-267

  Portugal, R D ^a   Land, M G P ^a   Svaiter, B F ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b IMPA   (Brazil)

Author keywords

Cultured stem cells; Growth; Model; Stochastic; Telomere

Indexed keywords

CELL ORGANELLE; GROWTH; NUMERICAL MODEL; STOCHASTICITY;

AGING; ARTICLE; CELL DIVISION; CELL GROWTH; COMPUTER SIMULATION; MATHEMATICAL MODEL; MESENCHYMAL STEM CELL; PROBABILITY; QUALITATIVE ANALYSIS; STOCHASTIC MODEL; TELOMERE;

EID: 37549009945     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2007.10.003     Document Type: Article

References (25)

1. Arino O., Kimmel M., and Webb G.F. Mathematical modeling of the loss of telomere sequences. J. Theor. Biol. 177 (1995) 45-57
2. Baxter M.A., Wynn R.F., Jowitt S.N., Wraith J.E., Fairbairn L.J., and Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22 (2004) 675-682
3. Begall S. The application of the Gompertz model to describe body growth. Growth Dev. Aging 61 (1997) 61-67
4. Bonab M.M., Alimoghaddam K., Talebian F., Ghaffari S.H., Ghavamzadeh A., and Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 10 (2006) 7-14
5. op den Buijs J., van den Bosch P.P., Musters M.W., and van Riel N.A. Mathematical modeling confirms the length-dependency of telomere shortening. Mech. Ageing Dev. 125 (2004) 437-444
6. Caplan A.I., and Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 7 (2001) 259-264
7. Demicheli R. Growth of testicular neoplasm lung metastases: tumor specific relation between two gompertzian parameters. Eur. J. Cancer 16 (1980) 1603-1608
8. Feldser D.M., and Greider C.W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11 (2007) 461-469
9. Gompertz B. On the nature of the function of the law of human mortality, etc. Philos. Trans. Roy. Soc. 115 (1825) 513
10. Greider C.W. Telomere length regulation. Annu. Rev. Biochem. 65 (1996) 337-365
11. Gupta N., Taneja R., Pandey A., Mukesh M., Singh H., and Gupta S.C. Replicative senescence, telomere shortening and cell proliferation rate in Gaddi goat's skin fibroblast cell line. Cell Biol Int. 31 (2007) 1257-1264
12. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37 (1965) 614-636
13. Laird A.K. Dynamics of relative growth. Growth 29 (1965) 249-263
14. Laird A.K., Tyler S.A., and Barton A.D. Dynamics of normal growth. Growth 29 (1965) 233-248
15. Laird A.K. Dynamics of growth in tumors and in normal organism. Natl. Cancer Inst. Monogr. 30 (1969) 15-28
16. Lin K.W., and Yan J. The telomere length dynamic and methods of its assessment. J. Cell. Mol. Med. 9 (2005) 977-989
17. Norton L. Gompertzian model of human breast cancer growth. Cancer Res. 48 (1988) 7067-7071
18. Pansky A., Roitzheim B., and Tobiasch E. Differentiation potential of adult human mesenchymal stem cells. Clin. Lab. 53 (2007) 81-84
19. Proctor C.J., and Kirkwood T.B.L. Modelling telomere shortening and the role of oxidative stress. Mech. Ageing Dev. 123 (2002) 351-363
20. Sedivy J.M. Telomeres limit cancer growth by inducing senescence: long-sought in vivo evidence obtained. Cancer Cell 11 (2007) 389-391
21. Shay J.W., and Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26 (2005) 867-874
22. Shin J.S., Hong A., Solomon M.J., and Soon Lee C. The role of telomeres and telomerase in the pathology of human cancer and aging. Pathology 382 (2006) 103-113
23. Sullivan P.W., and Salmon S.E. Kinetics of tumor growth and regression in IgG multiple myeloma. J. Clin. Invest. 51 (1972) 1608-1697
24. Zimmermann S., Voss M., Kaiser S., Kapp U., Waller C.F., and Martens U.M. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17 (2003) 1146-1149
25. Zimmermann S., and Martens U.M. Telomeres and telomerase as targets for cancer therapy. Cell. Mol. Life Sci. 64 (2007) 906-921